Table 1.
Participant demographic and symptom characteristics
| Clinical (n = 25) | Control (n = 58) | p-values | |
|---|---|---|---|
| Age in yearsa | 19.71 (2.8) | 19.56 (2.62) | .83 |
| N of females (%) | 76 | 58.6 | .13 |
| AUDIT | 6.44 (5.87) | 7.84 (5.92) | .32 |
| Systolic BPb | 119.32 (14.53) | 122.19 (13.42) | .4 |
| Diastolic BPb | 79.76 (13.15) | 75.81 (11.18) | .2 |
| BMIb | 21.31 (2.97) | 23.01 (4.16) | .04 |
| Symptom Measures | |||
| PSWQc | 60.5 (11.77) | 42 (11.85) | <.001 |
| DASS Dd | 20.5 (12.75) | 6.93 (8.41) | <.001 |
| DASS Ad | 18.67 (10.74) | 4.93 (6.23) | <.001 |
| DASS Sd | 24.67 (10) | 10.62 (8.16) | <.001 |
| STAI Se | 47.12 (11.37) | 32.96 (7.74) | <.001 |
Note: Means and standard deviations (in parentheses) are presented for continuous data; AUDIT Alcohol Use Disorders Identification Test, BMI Body mass index, PSQW Penn State Worry Questionnaire, DASS D Depression, Anxiety and Stress Scale (short-form) depression subscale, DASS21-A Depression, Anxiety and Stress Scale (short-form) anxiety subscale, DASS A Depression, Anxiety and Stress Scale (short-form) stress subscale, STAI S State-Trait Anxiety Inventory – State scale. aClinical n = 24, Control n = 55; bClinical n = 25, Control n = 57; cClinical n = 24, Control n = 57; dClinical n = 24, Control n = 58; eClinical n = 25, Control n = 55